跳至主要内容
临床试验/NCT03650153
NCT03650153已完成不适用

Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. Transperineal

Princess Al-Johara Al-Ibrahim Cancer Research Center1 个研究点 分布在 1 个国家目标入组 165 人开始时间: 2020年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
165
试验地点
1
主要终点
the rate of positive detections

研究概览

简要总结

This prospective study of comparing between Transrectal and transperineal prostate MRI targeted biopsy to provide evidence for clinicians to select the appropriate biopsy approach under different conditions.

详细描述

This prospective study of comparing transperineal (TP) prostate MRI targeted biopsy with transrectal (TR) prostate MRI targeted biopsy was aimed to provide evidence for clinicians to select the appropriate biopsy approach under different conditions. TP (n = 75) and TR (n = 75) will be performed randomly for 150 patients who are suspicious of prostate cancer (PCa). The cancer detection rate (CDR), complication rate, visual analog scale (VAS) score, most painful procedure, number of repeated biopsy and additional anesthesia, and operating time (starting from lying down on the operating table to getting up) will be recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double (Participant, Investigator)

入排标准

年龄范围
— 至 80 Years(Child, Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • prostate-specific antigen > 4ng/ml
  • Palpation is positive

排除标准

  • older than 80y
  • prostate-specific antigen > 100 ng/ml

结局指标

主要结局

the rate of positive detections

时间窗: 1 year

the rate of positive detections (How many case are Prostate cancer positive)

次要结局

  • the incidence rate of each complication(1 year)

研究者

发起方
Princess Al-Johara Al-Ibrahim Cancer Research Center
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验